2017 ACR适宜性标准:血管性跛行血运重建的评估

2017-05-14 J Am Coll Radiol. 2017 May;14(5S):S372-S379.

2017年5月,美国放射学会(ACR)发布了关于血管性跛行血运重建的影像评估标准。本文的主要内容包括应用无创血流动力学研究、动脉造影、无创影像学检查进行血管性跛行血运重建的评估的相关建议。

中文标题:

2017 ACR适宜性标准:血管性跛行血运重建的评估

英文标题:

ACR Appropriateness Criteria® Vascular Claudication-Assessment for Revascularization.

发布机构:

发布日期:

2017-05-14

简要介绍:

2017年5月,美国放射学会(ACR)发布了关于血管性跛行血运重建的影像评估标准。本文的主要内容包括应用无创血流动力学研究、动脉造影、无创影像学检查进行血管性跛行血运重建的评估的相关建议。


拓展指南:血管相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017 ACR适宜性标准:血管性跛行血运重建的评估)] GetToolGuiderByIdResponse(projectId=1, id=f1d601c001a6490b, title=2017 ACR适宜性标准:血管性跛行血运重建的评估, enTitle=ACR Appropriateness Criteria® Vascular Claudication-Assessment for Revascularization., guiderFrom=J Am Coll Radiol. 2017 May;14(5S):S372-S379., authorId=null, author=, summary=2017年5月,美国放射学会(ACR)发布了关于血管性跛行血运重建的影像评估标准。本文的主要内容包括应用无创血流动力学研究、动脉造影、无创影像学检查进行血管性跛行血运重建的评估的相关建议。, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sun May 14 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=2017年5月,美国放射学会(ACR)发布了关于血管性跛行血运重建的影像评估标准。本文的主要内容包括应用无创血流动力学研究、动脉造影、无创影像学检查进行血管性跛行血运重建的评估的相关建议。 <div><br> </div> 拓展指南:<strong>与<font color=red>血管</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=6895c1c001a5438c" title="2016 马来西亚女性心血管疾病预防指南(第2版)" target=_blank>2016 马来西亚女性心血管疾病预防指南(第2版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d9ca61c001a53352" title="中国心血管疾病临床病理标本处理与检测规范" target=_blank>中国心血管疾病临床病理标本处理与检测规范</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=dfd291c001a48eef" title="2017 国际专家共识:1级高血压和低至中度心血管风险患者抗高血压药物治疗" target=_blank>2017 国际专家共识:1级高血压和低至中度心血管风险患者抗高血压药物治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=6e7751c001a43046" title="英国孕产妇出血管理系列指南主要推荐及其启示(五) —产后出血预防和管理指南" target=_blank>英国孕产妇出血管理系列指南主要推荐及其启示(五) —产后出血预防和管理指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9585b1c001a3997c" title="冠状动脉微血管疾病诊断和治疗的中国专家共识" target=_blank>冠状动脉微血管疾病诊断和治疗的中国专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%A1%80%E7%AE%A1" target=_blank>有关血管更多指南</a></ul>, tagList=[TagDto(tagId=101406, tagName=血管性跛行血运重建的评估)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3608, appHits=181, showAppHits=0, pcHits=2840, showPcHits=1087, likes=166, shares=4, comments=12, approvalStatus=1, publishedTime=Thu Jun 29 15:12:28 CST 2017, publishedTimeString=2017-05-14, pcVisible=1, appVisible=1, editorId=5295982, editor=yanqin, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yanqin, createdTime=Thu Jun 29 15:12:28 CST 2017, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 03:46:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 ACR适宜性标准:血管性跛行血运重建的评估)])
2017 ACR适宜性标准:血管性跛行血运重建的评估
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=224347, encodeId=675922434e1f, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Thu Jul 20 18:30:14 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222541, encodeId=58cb22254187, content=很好 感谢 感谢 感谢 重要思维 三遍 非常 感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Sat Jul 15 10:44:59 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222141, encodeId=66512221416f, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jul 14 09:05:20 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221276, encodeId=66f62212e680, content=谢谢,文章 指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Wed Jul 12 07:11:13 CST 2017, time=2017-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=219450, encodeId=ebb921945031, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jul 07 09:14:06 CST 2017, time=2017-07-07, status=1, ipAttribution=)]
    2017-07-20 wxl882001

    学习一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=224347, encodeId=675922434e1f, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Thu Jul 20 18:30:14 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222541, encodeId=58cb22254187, content=很好 感谢 感谢 感谢 重要思维 三遍 非常 感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Sat Jul 15 10:44:59 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222141, encodeId=66512221416f, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jul 14 09:05:20 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221276, encodeId=66f62212e680, content=谢谢,文章 指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Wed Jul 12 07:11:13 CST 2017, time=2017-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=219450, encodeId=ebb921945031, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jul 07 09:14:06 CST 2017, time=2017-07-07, status=1, ipAttribution=)]
    2017-07-15 zwjnj2

    很好 感谢 感谢 感谢 重要思维 三遍 非常 感谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=224347, encodeId=675922434e1f, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Thu Jul 20 18:30:14 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222541, encodeId=58cb22254187, content=很好 感谢 感谢 感谢 重要思维 三遍 非常 感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Sat Jul 15 10:44:59 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222141, encodeId=66512221416f, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jul 14 09:05:20 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221276, encodeId=66f62212e680, content=谢谢,文章 指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Wed Jul 12 07:11:13 CST 2017, time=2017-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=219450, encodeId=ebb921945031, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jul 07 09:14:06 CST 2017, time=2017-07-07, status=1, ipAttribution=)]
    2017-07-14 Y—xianghai

    学习了新知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=224347, encodeId=675922434e1f, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Thu Jul 20 18:30:14 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222541, encodeId=58cb22254187, content=很好 感谢 感谢 感谢 重要思维 三遍 非常 感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Sat Jul 15 10:44:59 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222141, encodeId=66512221416f, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jul 14 09:05:20 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221276, encodeId=66f62212e680, content=谢谢,文章 指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Wed Jul 12 07:11:13 CST 2017, time=2017-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=219450, encodeId=ebb921945031, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jul 07 09:14:06 CST 2017, time=2017-07-07, status=1, ipAttribution=)]
    2017-07-12 flysky120

    谢谢,文章 指南

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=224347, encodeId=675922434e1f, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Thu Jul 20 18:30:14 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222541, encodeId=58cb22254187, content=很好 感谢 感谢 感谢 重要思维 三遍 非常 感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Sat Jul 15 10:44:59 CST 2017, time=2017-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=222141, encodeId=66512221416f, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jul 14 09:05:20 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221276, encodeId=66f62212e680, content=谢谢,文章 指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Wed Jul 12 07:11:13 CST 2017, time=2017-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=219450, encodeId=ebb921945031, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jul 07 09:14:06 CST 2017, time=2017-07-07, status=1, ipAttribution=)]
    2017-07-07 Y—xianghai

    学习了新知识

    0